All translations
Jump to navigation
Jump to search
Enter a message name below to show all available translations.
Found 2 translations.
| Name | Current message text |
|---|---|
| h English (en) | Later in 2021 and 2022, several cases of contamination with azido impurities were detected in losartan, irbesartan, and valsartan, prompting regulatory responses ranging from investigation to market withdrawals and precautionary recalls in [[Australia]], [[Brazil]], and Europe (including Switzerland). |
| h Japanese (ja) | その後、2021年と2022年にロサルタン、イルベサルタン、バルサルタンにアジド系不純物の混入が数例検出され、[[:en:Australia|オーストラリア]]、[[:en:Brazil|ブラジル]]、欧州（スイスを含む）で調査から市場撤去、予防的回収に至る規制当局の対応が行われた。 |